3rd Quarter - Report

CUNEO GILBERT & LADUCA for TEVA PHARMACEUTICALS USA

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Follow-on biologics H.R. 1427, S. 726

LobbyistCovered position, as disclosed
PAMELA BETH GILBERT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 726 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.